Health and Healthcare Systems

A timeline of our efforts to eradicate malaria - how close are we?

A health worker checks a blood sample for malaria in the only hospital in Pailin in western Cambodia January 28, 2010. Bordering with Thailand, this former Khmer Rouge stronghold and dusty gem mining town is now better known for a malarial parasite that is worrying health experts in the region. Studies and research show artemisinin-based therapies - currently the most effective treatment against malaria - are taking longer to cure some of the patients.  REUTERS/Damir Sagolj (CAMBODIA - Tags: HEALTH POLITICS SOCIETY) - RTR29KVT

To outpace rising resistance, Seattle's malaria-fighting community is developing innovations. Image: REUTERS/Damir Sagolj

Katy Migiro
East Africa correspondent, Thomson Reuters Foundation
Kieran Guilbert
Reporter, Reuters
Our Impact
What's the World Economic Forum doing to accelerate action on Health and Healthcare Systems?
The Big Picture
Explore and monitor how Global Health is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:

Future of Global Health and Healthcare

In Seattle, which has been dubbed the "Silicon Valley of saving lives", thousands of scientists, engineers and entrepreneurs are working on innovations to end malaria.

The city boasts at least 160 organisations working on global health and is home to the world's richest couple, Bill and Melinda Gates, whose global health and education foundation has set a target to eradicate the deadly disease by 2040.

Yet efforts to end malaria, which killed an estimated 438,000 people in 2015, are under threat as mosquitoes become increasingly resistant to drugs and insecticides.

To outpace rising resistance, Seattle's malaria-fighting community is developing innovations ranging from data modelling and genetic modification to single-dose drugs and sugar traps.

Free of malaria world map
Image: World Economic Forum

Here are key dates in the drive to end malaria:

1947 - The United States launches the National Malaria Eradication Program. The disease had caused widespread illness among soldiers training in the southern U.S. during World War Two. Almost 5 million homes are sprayed with DDT insecticide and mosquito breeding sites are drained.

1951 - Malaria is eliminated in the United States.

1955 - The World Health Organization (WHO) launches the Global Malaria Eradication Program (GMEP). Malaria is eliminated in more than two dozen countries in Europe, the Americas and Asia, mainly by spraying with DDT and using the cheap and effective drug chloroquine. Most of Africa is excluded due to logistical difficulties.

1969 - The WHO suspends GMEP due to drug and insecticide resistance and funding shortages.

1975 - Europe is declared malaria free. The disease had been endemic in southern countries like Italy, Greece and Portugal.

1979 - Tunisia eliminates malaria.

1987 - Scientists working in GlaxoSmithKline laboratories create the Mosquirix malaria vaccine candidate.

1990s - Malaria re-emerges in Europe's Caucasus region, Central Asia, the Russian Federation and Turkey due to population movements and reduced prevention measures.

1998 - WHO launches the Roll Back Malaria initiative, leading to increased investment in cheap new drugs, tests and insecticide-treated bed nets.

2005 - President George W. Bush sets up the U.S. President's Malaria Initiative with the aim of halving malaria-related deaths in 15 high-burden African countries.

2007 - Results of phase II clinical trials of Mosquirix in Mozambique show it provides partial protection against malaria.

2009 - Mosquirix phase III field trials begin. It is Africa's largest malaria vaccine trial to date, involving 15,000 infants and children in seven countries.

2010 - Morocco eliminates malaria.

2011 - Trial data from Africa shows Mosquirix halves the number of malaria episodes in children aged five to 17 months.

2014 - A study in the New England Journal of Medicine finds widespread resistance to the world's most effective antimalarial drug, artemisinin, across Southeast Asia, threatening global control efforts.

2015 - Mosquirix receives a green light from European Union drug regulators who recommend it to be licensed for use.

2015 - The world meets the Millennium Development Goal to halt and reverse the incidence of malaria. Global leaders set a Sustainable Development Goal to end epidemic levels of malaria by 2030.

2016 - The WHO invites African countries to take part in a Mosquirix vaccine pilot involving up to 800,000 children aged five to nine months.

Sources: U.S. Centers for Disease Control and Prevention, World Health Organization, PATH Malaria Vaccine Initiative, U.S. President's Malaria Initiative.

This article is published in collaboration with The Thomson Reuters Foundation Publication does not imply endorsement of views by the World Economic Forum.

To keep up with the Agenda subscribe to our weekly newsletter.

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

Feeding the future: why Renovation and Reinvention are key to saving our food system

Juliana Weltman Glezer

June 13, 2024

About Us



Partners & Members

  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2024 World Economic Forum